当前位置:首页 - 行情中心 - 兰卫医学(301060) - 财务分析 - 现金流量表

兰卫医学

(301060)

  

流通市值:43.29亿  总市值:48.14亿
流通股本:3.60亿   总股本:4.01亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金698,034,176.38347,432,560.121,635,208,018.11,203,495,752.18
  收到的税费返还--0-
  收到其他与经营活动有关的现金13,658,988.446,242,418.8232,165,082.7920,557,668.06
  经营活动现金流入小计711,693,164.82353,674,978.941,667,373,100.891,224,053,420.24
  购买商品、接受劳务支付的现金381,364,972.18158,403,122.54966,028,505.01719,708,529.91
  支付给职工以及为职工支付的现金118,498,700.9764,786,877.08268,481,278.48196,678,257.82
  支付的各项税费19,082,257.887,281,317.8150,483,516.7238,582,955.34
  支付其他与经营活动有关的现金39,892,463.3121,069,757.44113,526,020.7797,324,785.82
  经营活动现金流出小计558,838,394.34251,541,074.871,398,519,320.981,052,294,528.89
  经营活动产生的现金流量净额152,854,770.48102,133,904.07268,853,779.91171,758,891.35
二、投资活动产生的现金流量:
  收回投资收到的现金2,034,200,0001,102,800,0001,907,730,0001,194,930,000
  取得投资收益收到的现金3,773,806.921,751,391.864,070,899.112,851,854.99
  处置固定资产、无形资产和其他长期资产收回的现金净额2,779,107.79574,8107,844,060.343,312,470
  处置子公司及其他营业单位收到的现金净额42,092.3827,9603,519,690.613,331,500
  收到的其他与投资活动有关的现金300,000-306,446.3-
  投资活动现金流入小计2,041,095,007.091,105,154,161.861,923,471,096.361,204,425,824.99
  购建固定资产、无形资产和其他长期资产支付的现金15,671,928.263,807,905.7258,491,119.1536,112,830.56
  投资支付的现金1,974,200,0001,042,800,0001,987,564,7001,194,930,000
  取得子公司及其他营业单位支付的现金--0-
  支付其他与投资活动有关的现金--300,000-
  投资活动现金流出小计1,989,871,928.261,046,607,905.722,046,355,819.151,231,042,830.56
  投资活动产生的现金流量净额51,223,078.8358,546,256.14-122,884,722.79-26,617,005.57
三、筹资活动产生的现金流量:
  吸收投资收到的现金--0-
  其中:子公司吸收少数股东投资收到的现金--0-
  取得借款收到的现金--50,000,00050,000,000
  收到其他与筹资活动有关的现金--0100,000
  筹资活动现金流入平衡项目--00
  筹资活动现金流入小计--50,000,00050,100,000
  偿还债务支付的现金54,699,857.19,099,857.1135,800,000110,000,000
  分配股利、利润或偿付利息支付的现金78,887,855.162,274,634.18172,617,831.16157,917,270.79
  其中:子公司支付给少数股东的股利、利润--79,920,00073,800,000
  支付其他与筹资活动有关的现金7,261,169.542,805,046.4215,313,347.59,790,147.31
  筹资活动现金流出小计140,848,881.814,179,537.7323,731,178.66277,707,418.1
  筹资活动产生的现金流量净额-140,848,881.8-14,179,537.7-273,731,178.66-227,607,418.1
四、汇率变动对现金及现金等价物的影响-3,517-1,570.96-29,451.71-27,346.41
五、现金及现金等价物净增加额63,225,450.51146,499,051.55-127,791,573.25-82,492,878.73
  加:期初现金及现金等价物余额697,955,751.32697,955,751.32825,747,324.57825,747,324.57
  期末现金及现金等价物余额761,181,201.83844,454,802.87697,955,751.32743,254,445.84
补充资料:
  净利润68,552,669.65--15,422,510.31-
  资产减值准备-41,564,736.5-19,203,083.41-
  固定资产和投资性房地产折旧25,752,558.05-61,705,508-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧25,752,558.05-61,705,508-
  无形资产摊销2,202,779.11-5,012,872.24-
  长期待摊费用摊销6,073,123.38-23,872,185.49-
  处置固定资产、无形资产和其他长期资产的损失182,502.7-1,233,336.93-
  固定资产报废损失258,750.52-1,199,532.35-
  公允价值变动损失---51,715.73-
  财务费用1,870,197.68-6,437,342.79-
  投资损失-3,677,157.79--6,442,536.71-
  递延所得税10,275,876.21-14,161,336.61-
  其中:递延所得税资产减少10,270,387.93-16,595,891.48-
    递延所得税负债增加5,488.28--2,434,554.87-
  存货的减少25,123,602.38-32,153,737.93-
  经营性应收项目的减少65,634,670.35-117,945,290.31-
  经营性应付项目的增加-13,997,531.38--5,609,418.08-
  其他816,666.66-936,666.67-
  现金的期末余额761,181,201.83-697,955,751.32-
  减:现金的期初余额697,955,751.32-825,747,324.57-
  现金及现金等价物的净增加额63,225,450.51--127,791,573.25-
公告日期2026-08-222026-04-292026-04-292025-10-28
审计意见(境内)标准无保留意见
TOP↑